[1] |
Peterson LS, Nelson AM, Su WP. Classification of morphea (localized scleroderma)[J]. Mayo Clin Proc, 1995,70(11):1068⁃1076. doi: 10.4065/70.11.1068.
|
[2] |
Zulian F, Athreya BH, Laxer R, et al. Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study[J]. Rheumatology (Oxford), 2006,45(5):614⁃620. doi: 10.1093/rheumatology/kei251.
|
[3] |
Kreuter A, Krieg T, Worm M, et al. German guidelines for the diagnosis and therapy of localized scleroderma[J]. J Dtsch Dermatol Ges, 2016,14(2):199⁃216. doi: 10.1111/ddg.12724.
|
[4] |
Röcken M, Ghoreschi K. Morphea and lichen sclerosus[M]// Bolognia JL, Schaffer JV, Cerroni L. Dermatology. 4th ed. USA: Elsevier, 2018:707⁃721.
|
[5] |
Goodfield MJD, Jones SK, Veale DJ. The ′connective tissue diseases′[M]// Burns T, Breathnach S, Cox N, Griffiths C. Rook′s textbook of dermatology. 8th ed. Hoboken: Wiley⁃Blackwell, 2010:51,64⁃87.
|
[6] |
James WD, Berger TG, Elston DK. Connective tissue diseases[M]// James WD, Berger TG, Elston DK. Andrews′ diseases of the skin: clinical dermatology. 12th ed. Philadelphia: Saunders Elsevier, 2019:167⁃178.
|
[7] |
Kencka D, Blaszczyk M, Jabłońska S. Atrophoderma Pasini⁃Pierini is a primary atrophic abortive morphea[J]. Dermatology, 1995,190(3):203⁃206. doi: 10.1159/000246685.
|
[8] |
Kellet CV, Orteu CH, Dutz JP. Localized scleroderma[M]// Hertl M. Autoimmune diseases of the skin: pathogenesis, diagnosis, management. 3rd ed. New York: Springer Wien New York, 2011:137⁃172.
|
[9] |
李明. 硬斑病[M]//赵辨. 中国临床皮肤病学. 2版. 南京: 江苏凤凰科学技术出版社, 2017:878⁃885.
|
[10] |
李峰, 李明, 朱小华, 等. 免疫性结缔组织病[M]//王侠生, 徐金华, 张学军. 现代皮肤病学. 2版. 上海: 上海大学出版社, 2020:730⁃799.
|
[11] |
Daoud MS, Su WP, Leiferman KM, et al. Bullous morphea: clinical, pathologic, and immunopathologic evaluation of thirteen cases[J]. J Am Acad Dermatol, 1994,30(6):937⁃943. doi: 10.1016/s0190⁃9622(94)70113⁃x.
|
[12] |
Su WP, Greene SL. Bullous morphea profunda[J]. Am J Dermatopathol, 1986,8(2):144⁃147. doi: 10.1097/00000372⁃198604000⁃00009.
|
[13] |
樊雪, 朱晨雨, 毛笑非, 等. 局限性硬皮病522例临床分析[J]. 临床皮肤科杂志, 2016,45(1):5⁃10. doi: 10.16761/j.cnki.1000⁃4963.2016.01.003.
|
[14] |
周海燕, 唐鹤菡, 陈冲, 等. 线状硬斑病107例临床及影像学特点回顾性分析[J]. 中华皮肤科杂志, 2021,54(9):798⁃803. doi: 10.35541/cjd.20201056.
|
[15] |
Skrzypek⁃Salamon A, Lis⁃Święty A, Ranosz⁃Janicka I, et al. Localized Scleroderma Cutaneous Assessment Tool (LoSCAT) adapted for use in adult patients: report from an initial validation study[J]. Health Qual Life Outcomes, 2018,16(1):185. doi: 10.1186/s12955⁃018⁃1010⁃z.
|
[16] |
Peterson LS, Nelson AM, Su WP, et al. The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993[J]. J Rheumatol, 1997,24(1):73⁃80.
|
[17] |
Vieira⁃Damiani G, Lage D, Christofoletti DPÉ, et al. Idiopathic atrophoderma of Pasini and Pierini: a case study of collagen and elastin texture by multiphoton microscopy[J]. J Am Acad Dermatol, 2017,77(5):930⁃937. doi: 10.1016/j.jaad.2017.02.044.
|
[18] |
Jablonska S, Szczepanski A. Atrophoderma Pasini⁃Pierini: is it an entity?[J]. Dermatologica, 1962,125:226⁃242.
|
[19] |
Amano H, Nagai Y, Ishikawa O. Multiple morphea coexistent with atrophoderma of Pasini⁃Pierini (APP): APP could be abortive morphea[J]. J Eur Acad Dermatol Venereol, 2007,21(9):1254⁃1256. doi: 10.1111/j.1468⁃3083.2006.02131.x.
|
[20] |
Jablonska S, Blaszczyk M. Is superficial morphea synonymous with atrophoderma Pasini⁃Pierini?[J]. J Am Acad Dermatol, 2004,50(6):979⁃980; author reply 980. doi: 10.1016/j.jaad.2003. 11.088.
|
[21] |
Toledano C, Rabhi S, Kettaneh A, et al. Localized scleroderma: a series of 52 patients[J]. Eur J Intern Med, 2009,20(3):331⁃336. doi: 10.1016/j.ejim.2008.07.011.
|
[22] |
Ang GC, Lee JB. Linear atrophoderma of Moulin: is it a single disease?[J]. J Am Acad Dermatol, 2005,52(5):923⁃924; author reply 924⁃925. doi: 10.1016/j.jaad.2004.09.043.
|
[23] |
Moss C, Shahidullah H. Naevi and other developmental defects[M]//Burns T, Breathnach S, Cox N, et al. Rook′s textbook of dermatology. 8th ed. Hoboken: Wiley⁃Blackwell, 2010:18.1.
|
[24] |
Jablonska S. Facial hemiatrophy and its relation to localized scleroderma[M]//Jablonska S. Scleroderma and pseudosclero⁃derma. Poland: PZWL, 1975:537⁃548.
|
[25] |
Diaz⁃Perez JL, Connolly SM, Winkelmann RK. Disabling pansclerotic morphea of children[J]. Arch Dermatol, 1980,116(2):169⁃173.
|
[26] |
Devidayal, Singh S, Kumar L, et al. Disabling pansclerotic morphea of childhood and hypogammaglobulinemia: a curious association[J]. Rheumatol Int, 2002,21(4):158⁃160. doi: 10.1007/s00296⁃001⁃0150⁃2.
|
[27] |
张韡, 陈浩, 徐秀莲, 等. 致残性全硬化性硬斑病六例临床病理特点分析[J]. 中华皮肤科杂志, 2018,51(8):561⁃563. doi: 10.3760/cma.j.issn.0412⁃4030.2018.08.001.
|
[28] |
Khatri S, Torok KS, Mirizio E, et al. Autoantibodies in morphea: an update[J]. Front Immunol, 2019,10:1487. doi: 10.3389/fimmu.2019.01487.
|
[29] |
Zulian F, Vallongo C, Woo P, et al. Localized scleroderma in childhood is not just a skin disease[J]. Arthritis Rheum, 2005,52(9):2873⁃2881. doi: 10.1002/art.21264.
|
[30] |
Kreuter A, Wischnewski J, Terras S, et al. Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center[J]. J Am Acad Dermatol, 2012,67(6):1157⁃1162. doi: 10.1016/j.jaad.2012.04.003.
|
[31] |
Lutz V, Francès C, Bessis D, et al. High frequency of genital lichen sclerosus in a prospective series of 76 patients with morphea: toward a better understanding of the spectrum of morphea[J]. Arch Dermatol, 2012,148(1):24⁃28. doi: 10.1001/archdermatol.2011.305.
|
[32] |
Vanhaecke A, De Schepper S, Paolino S, et al. Coexistence of systemic and localized scleroderma: a systematic literature review and observational cohort study[J]. Rheumatology (Oxford), 2020,59(10):2725⁃2733. doi: 10.1093/rheumatology/keaa297.
|
[33] |
Lis⁃Święty A, Skrzypek⁃Salamon A, Ranosz⁃Janicka I, et al. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood⁃versus childhood⁃onset disease differences[J]. J Eur Acad Dermatol Venereol, 2017,31(10):1595⁃1603. doi: 10.1111/jdv.14197.
|